Fludeoxyglucose F-18 (FDG)
The radioactive sugar used in almost every cancer PET scan, approved in the 1990s and made fresh each day by regional cyclotrons.
Overview
Fludeoxyglucose F-18 was the first PET radiopharmaceutical approved by the FDA (1994, initially for epilepsy foci and cardiac viability) and gained its oncology indication in 2000 for assessing abnormal glucose metabolism to assist in evaluating malignancy in patients with known or suspected cancer. It is produced under multiple abbreviated NDAs by commercial and academic cyclotron networks (PETNET, Cardinal Health, SOFIE, hospital sites) and is the tracer behind staging, response assessment (Deauville in lymphoma, PERCIST) and surveillance across most solid tumours. Its weaknesses, uptake in inflammation and poor sensitivity for indolent or low-glucose tumours, drive the development of target-specific tracers.
Approvals
| Region | Year | Indication |
|---|---|---|
| US | 1994 | First FDG NDA (neurology and cardiology indications) |
| US | 2000 | Oncology: assessment of abnormal glucose metabolism to assist in evaluating malignancy |
Trials
topRecruiting now (live from ClinicalTrials.gov)
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Notes
top- What a result means: 'hot spots' show tissue burning glucose fast; in a person with cancer they usually mark tumour, but infection, healing and brown fat can light up too, so findings are interpreted with CT and biopsy.
Latest papers
topQuery for this drug: (TITLE:"Fludeoxyglucose F-18" OR ABSTRACT:"Fludeoxyglucose F-18" OR TITLE:"FDG" OR ABSTRACT:"FDG" OR TITLE:"multiple manufacturers" OR ABSTRACT:"multiple manufacturers") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Fludeoxyglucose F-18 (FDG), not a curated reading list.
Pages like this
not linked directly; found by shared links- ProductIlluccix (kit for Ga-68 gozetotide)
Shares PET/CT and the tag test.
- ProductLocametz (kit for Ga-68 gozetotide)
Shares PET/CT and the tag test.
- TechnologyPET tracer manufacturing and distribution
Shares PETNET Solutions (Siemens Healthineers), Cardinal Health Nuclear & Precision Health Solutions, SOFIE Biosciences, PET (positron emission tomography).
- TechnologyRadiopharmacy and cyclotron networks
Shares PETNET Solutions (Siemens Healthineers), Cardinal Health Nuclear & Precision Health Solutions, SOFIE Biosciences, PET (positron emission tomography).
- IdeaDe-acidify the tumour so T cells can work in it
Shares Standardised uptake value (SUV), FDG PET.
- InstitutionSociety of Nuclear Medicine and Molecular Imaging
Shares Standardised uptake value (SUV), FDG PET, PET (positron emission tomography), PET/CT.
- IdeaA phase 0 fund to test academic compounds in humans with microdoses and imaging
Shares Standardised uptake value (SUV), PET (positron emission tomography).
- ProductFluoroestradiol F-18 (FES PET)
Shares PET (positron emission tomography), PET/CT.